Intech Investment Management LLC trimmed its position in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 72.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,922 shares of the company's stock after selling 21,050 shares during the period. Intech Investment Management LLC's holdings in Molina Healthcare were worth $2,609,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Rothschild Investment LLC grew its stake in Molina Healthcare by 126.3% during the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after buying an additional 48 shares in the last quarter. Zions Bancorporation National Association UT acquired a new stake in shares of Molina Healthcare in the 1st quarter valued at approximately $29,000. Deseret Mutual Benefit Administrators boosted its stake in shares of Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after purchasing an additional 34 shares in the last quarter. Elequin Capital LP boosted its stake in shares of Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after purchasing an additional 58 shares in the last quarter. Finally, Silver Oak Securities Incorporated acquired a new stake in shares of Molina Healthcare in the 1st quarter valued at approximately $34,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Trading Down 2.6%
NYSE:MOH traded down $4.62 during mid-day trading on Friday, hitting $175.09. 2,063,581 shares of the company's stock were exchanged, compared to its average volume of 1,239,660. The company has a 50 day simple moving average of $174.11 and a 200-day simple moving average of $262.02. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a fifty-two week low of $151.95 and a fifty-two week high of $359.97. The firm has a market capitalization of $9.49 billion, a P/E ratio of 8.63 and a beta of 0.54.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. During the same quarter in the prior year, the business earned $5.86 earnings per share. The firm's quarterly revenue was up 15.7% on a year-over-year basis. As a group, research analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Insider Activity at Molina Healthcare
In other news, COO James Woys purchased 10,000 shares of the stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the acquisition, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director owned 17,131 shares of the company's stock, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
MOH has been the topic of a number of research analyst reports. UBS Group reduced their price target on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Truist Financial restated a "hold" rating and issued a $180.00 price target (down from $335.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Barclays reduced their price target on shares of Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating on the stock in a research note on Thursday, September 4th. Finally, Cantor Fitzgerald reiterated a "neutral" rating and set a $210.00 target price on shares of Molina Healthcare in a research report on Tuesday, August 26th. Three analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $225.18.
View Our Latest Stock Analysis on Molina Healthcare
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.